Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,689 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unintended Deformation of Stents During Bifurcation PCI: An OCTOBER Trial Substudy.
Andreasen LN, Neghabat O, Laanmets P, Kumsars I, Bennett J, Olsen NT, Odenstedt J, Burzotta F, Johnson TW, O'Kane P, Hartikainen JEK, Spratt JC, Christiansen EH, Holm NR. Andreasen LN, et al. Among authors: bennett j. JACC Cardiovasc Interv. 2024 May 13;17(9):1106-1115. doi: 10.1016/j.jcin.2024.03.013. JACC Cardiovasc Interv. 2024. PMID: 38749590 Clinical Trial.
Healing responses after bifurcation stenting with the dedicated TRYTON Side-Branch Stent™ in combination with XIENCE-V™ stents: a clinical, angiography, fractional flow reserve, and optical coherence tomography study: the PYTON (Prospective evaluation of the TRYTON Side-Branch Stent™ with an additional XIENCE-v™ everolimus-eluting stent in coronary bifurcation lesions) study.
Dubois C, Adriaenssens T, Ughi G, Wiyono S, Bennett J, Coosemans M, Ferdinande B, Sinnaeve P, D'hooge J, Desmet W. Dubois C, et al. Among authors: bennett j. Catheter Cardiovasc Interv. 2013 Feb;81(3):E155-64. doi: 10.1002/ccd.24536. Epub 2012 Nov 14. Catheter Cardiovasc Interv. 2013. PMID: 22745031
COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial.
Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi GJ, Sinnaeve P, Vrolix M, D'hooge J, Adriaenssens T. Dubois C, et al. Among authors: bennett j. EuroIntervention. 2016 Apr 20;11(13):1457-67. doi: 10.4244/EIJY15M05_02. EuroIntervention. 2016. PMID: 25947278 Free article. Clinical Trial.
Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
Bennett J, Adriaenssens T, Desmet W, Dubois C. Bennett J, et al. Catheter Cardiovasc Interv. 2016 Nov 15;88(6):843-853. doi: 10.1002/ccd.26571. Epub 2016 May 17. Catheter Cardiovasc Interv. 2016. PMID: 27184586 Clinical Trial.
5-Year clinical follow-up of the COBRA (complex coronary bifurcation lesions: Randomized comparison of a strategy using a dedicated self-expanding biolimus A9-eluting stent vs. a culotte strategy using everolimus-eluting stents) study.
Bennett J, Adriaenssens T, McCutcheon K, Dens J, Desmet W, Sinnaeve P, Vrolix M, Dubois C. Bennett J, et al. Catheter Cardiovasc Interv. 2018 Nov 15;92(6):E375-E380. doi: 10.1002/ccd.27597. Epub 2018 Mar 14. Catheter Cardiovasc Interv. 2018. PMID: 29536609 Clinical Trial.
The Tryton® dedicated bifurcation stent: Five-year clinical outcomes.
Green PG, Stella PR, Kumsārs I, Dens J, Sonck J, Bennett J, Bethencourt A, López BR, Dudek D, van Geuns RJ, Ramcharitar S. Green PG, et al. Among authors: bennett j. Cardiovasc Revasc Med. 2019 Apr;20(4):316-323. doi: 10.1016/j.carrev.2018.06.023. Epub 2018 Jul 4. Cardiovasc Revasc Med. 2019. PMID: 30037716
5,689 results